Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas

BACKGROUND: Immunotherapies targeting glioblastoma (GBM) have led to significant improvements in patient outcomes. TOX is closely associated with the immune environment surrounding tumors, but its role in gliomas is not fully understood. METHODS: Using data from The Cancer Genome Atlas (TCGA) and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Hao, Fan, Fan, Yu, Yuanqiang, Wang, Zeyu, Liu, Fangkun, Dai, Ziyu, Zhang, Liyang, Liu, Zhixiong, Cheng, Quan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409670/
https://www.ncbi.nlm.nih.gov/pubmed/32762688
http://dx.doi.org/10.1186/s12967-020-02460-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409670/
https://www.ncbi.nlm.nih.gov/pubmed/32762688
http://dx.doi.org/10.1186/s12967-020-02460-3

Ejemplares similares